{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T17:19:42Z","timestamp":1761844782337},"reference-count":36,"publisher":"Spandidos Publications","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.3892\/mmr.2017.7648","type":"journal-article","created":{"date-parts":[[2017,9,28]],"date-time":"2017-09-28T06:29:46Z","timestamp":1506580186000},"page":"8200-8208","source":"Crossref","is-referenced-by-count":24,"title":["Iguratimod prevents ovariectomy-induced bone loss and suppresses osteoclastogenesis via inhibition of peroxisome proliferator-activated receptor-\u03b3"],"prefix":"10.3892","volume":"16","author":[{"given":"Ying-Xing","family":"Wu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yue","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ya-Ping","family":"Ye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jia-Chao","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun-Ming","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xing-Zhi","family":"Jing","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Xiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shi-Ying","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Feng-Jing","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2017,9,28]]},"reference":[{"key":"key20180108005637_b1-mmr-16-06-8200","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/nature01658","article-title":"Osteoclast differentiation and activation","volume":"423","author":"Boyle","year":"2003","journal-title":"Nature"},{"key":"key20180108005637_b2-mmr-16-06-8200","doi-asserted-by":"crossref","first-page":"2250","DOI":"10.1056\/NEJMra053077","article-title":"Bone quality-the material and structural basis of bone strength and fragility","volume":"354","author":"Seeman","year":"2006","journal-title":"N Engl J Med"},{"key":"key20180108005637_b3-mmr-16-06-8200","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.lfs.2016.01.024","article-title":"Natural products for treatment of osteoporosis: The effects and mechanisms on promoting osteoblast-mediated bone formation","volume":"147","author":"An","year":"2016","journal-title":"Life Sci"},{"key":"key20180108005637_b4-mmr-16-06-8200","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1038\/nrendo.2013.179","article-title":"The role of estrogen and androgen receptors in bone health and disease","volume":"9","author":"Manolagas","year":"2013","journal-title":"Nat Rev Endocrinol"},{"key":"key20180108005637_b5-mmr-16-06-8200","doi-asserted-by":"crossref","first-page":"29851","DOI":"10.1074\/jbc.M112.377945","article-title":"Receptor activator of nuclear factor \u03baB ligand (RANKL) protein expression by B lymphocytes contributes to ovariectomy-induced bone loss","volume":"287","author":"Onal","year":"2012","journal-title":"J Biol Chem"},{"key":"key20180108005637_b6-mmr-16-06-8200","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1084\/jem.190.12.1741","article-title":"Commitment and differentiation of osteoclast precursor cells by the sequential expression of c-Fms and receptor activator of nuclear factor kappaB (RANK) receptors","volume":"190","author":"Arai","year":"1999","journal-title":"J Exp Med"},{"key":"key20180108005637_b7-mmr-16-06-8200","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0092-8674(00)81569-X","article-title":"Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation","volume":"93","author":"Lacey","year":"1998","journal-title":"Cell"},{"key":"key20180108005637_b8-mmr-16-06-8200","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1016\/j.bbrc.2016.11.160","article-title":"The inhibitory effect of beta-lapachone on RANKL-induced osteoclastogenesis","volume":"482","author":"Gu","year":"2017","journal-title":"Biochem Biophys Res Commun"},{"key":"key20180108005637_b9-mmr-16-06-8200","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1111\/j.0105-2896.2005.00332.x","article-title":"Fos\/AP-1 proteins in bone and the immune system","volume":"208","author":"Wagner","year":"2005","journal-title":"Immunol Rev"},{"key":"key20180108005637_b10-mmr-16-06-8200","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1002\/jbmr.242","article-title":"Maslinic acid suppresses osteoclastogenesis and prevents ovariectomy-induced bone loss by regulating RANKL-mediated NF-\u03baB and MAPK signaling pathways","volume":"26","author":"Li","year":"2011","journal-title":"J Bone Miner Res"},{"key":"key20180108005637_b11-mmr-16-06-8200","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1196\/annals.1402.071","article-title":"The role of NFAT in osteoclast formation","volume":"1116","author":"Takayanagi","year":"2007","journal-title":"Ann N Y Acad Sci"},{"key":"key20180108005637_b12-mmr-16-06-8200","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.bone.2016.08.024","article-title":"Activation of dimeric glucocorticoid receptors in osteoclast progenitors potentiates RANKL induced mature osteoclast bone resorbing activity","volume":"93","author":"Conaway","year":"2016","journal-title":"Bone"},{"key":"key20180108005637_b13-mmr-16-06-8200","first-page":"2591","article-title":"Inhibitory effect of T-614 on tumor necrosis factor-alpha induced cytokine production and nuclear factor-kappaB activation in cultured human synovial cells","volume":"28","author":"Kohno","year":"2001","journal-title":"J Rheumatol"},{"key":"key20180108005637_b14-mmr-16-06-8200","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/S0022-2143(99)90186-5","article-title":"Inhibitory effect of a new anti-rheumatic drug T-614 on costimulatory molecule expression, cytokine production, and antigen presentation by synovial cells","volume":"133","author":"Kawakami","year":"1999","journal-title":"J Lab Clin Med"},{"key":"key20180108005637_b15-mmr-16-06-8200","doi-asserted-by":"crossref","first-page":"R136","DOI":"10.1186\/ar2554","article-title":"T-614, a novel immunomodulator, attenuates joint inflammation and articular damage in collagen-induced arthritis","volume":"10","author":"Du","year":"2008","journal-title":"Arthritis Res Ther"},{"key":"key20180108005637_b16-mmr-16-06-8200","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1038\/nm1672","article-title":"PPAR-gamma regulates osteoclastogenesis in mice","volume":"13","author":"Wan","year":"2007","journal-title":"Nat Med"},{"key":"key20180108005637_b17-mmr-16-06-8200","doi-asserted-by":"crossref","first-page":"4969","DOI":"10.4049\/jimmunol.1300832","article-title":"A novel disease-modifying antirheumatic drug, iguratimod, ameliorates murine arthritis by blocking IL-17 signaling, distinct from methotrexate and leflunomide","volume":"191","author":"Luo","year":"2013","journal-title":"J Immunol"},{"key":"key20180108005637_b18-mmr-16-06-8200","doi-asserted-by":"crossref","first-page":"2485","DOI":"10.3892\/mmr.2016.4849","article-title":"Electroacupuncture stimulation at CV4 prevents ovariectomy-induced osteoporosis in rats via Wnt-\u03b2-catenin signaling","volume":"13","author":"Fan","year":"2016","journal-title":"Mol Med Rep"},{"key":"key20180108005637_b19-mmr-16-06-8200","first-page":"8608","article-title":"Effects of icariin on orthodontic tooth movement in rats","volume":"8","author":"Chen","year":"2015","journal-title":"Int J Clin Exp Med"},{"key":"key20180108005637_b20-mmr-16-06-8200","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1038\/nature02444","article-title":"Costimulatory signals mediated by the ITAM motif cooperate with RANKL for bone homeostasis","volume":"428","author":"Koga","year":"2004","journal-title":"Nature"},{"key":"key20180108005637_b21-mmr-16-06-8200","doi-asserted-by":"crossref","first-page":"13575","DOI":"10.1038\/srep13575","article-title":"Amlexanox suppresses osteoclastogenesis and prevents ovariectomy-induced bone loss","volume":"5","author":"Zhang","year":"2015","journal-title":"Sci Rep"},{"key":"key20180108005637_b22-mmr-16-06-8200","doi-asserted-by":"crossref","first-page":"3451","DOI":"10.3892\/mmr.2015.3204","article-title":"Amiloride inhibits osteoclastogenesis by suppressing nuclear factor-\u03baB and mitogen-activated protein kinase activity in receptor activator of nuclear factor-\u03baB-induced RAW264.7 cells","volume":"11","author":"Wang","year":"2015","journal-title":"Mol Med Rep"},{"key":"key20180108005637_b23-mmr-16-06-8200","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1096\/fj.14-262055","article-title":"Epoxyeicosanoids suppress osteoclastogenesis and prevent ovariectomy-induced bone loss","volume":"29","author":"Guan","year":"2015","journal-title":"FASEB J"},{"key":"key20180108005637_b24-mmr-16-06-8200","doi-asserted-by":"crossref","first-page":"e88839","DOI":"10.1172\/jci.insight.88839","article-title":"Pulsed low-dose RANKL as a potential therapeutic for postmenopausal osteoporosis","volume":"1","author":"Cline-Smith","year":"2016","journal-title":"JCI Insight"},{"key":"key20180108005637_b25-mmr-16-06-8200","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1007\/s11596-016-1646-z","article-title":"Anti-rheumatic drug iguratimod (T-614) alleviates cancer-induced bone destruction via down-regulating interleukin-6 production in a nuclear factor-\u03baB-dependent manner","volume":"36","author":"Sun","year":"2016","journal-title":"J Huazhong Univ Sci Technolog Med Sci"},{"key":"key20180108005637_b26-mmr-16-06-8200","doi-asserted-by":"crossref","first-page":"S834","DOI":"10.1002\/cncr.11132","article-title":"Mechanisms of osteolytic bone metastases in breast carcinoma","volume":"97","author":"K\u00e4k\u00f6nen","year":"2003","journal-title":"Cancer"},{"key":"key20180108005637_b27-mmr-16-06-8200","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1007\/s10555-012-9372-x","article-title":"Genes associate with abnormal bone cell activity in bone metastasis","volume":"31","author":"Roodman","year":"2012","journal-title":"Cancer Metastasis Rev"},{"key":"key20180108005637_b28-mmr-16-06-8200","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1126\/science.1621100","article-title":"Increased osteoclast development after estrogen loss: Mediation by interleukin-6","volume":"257","author":"Jilka","year":"1992","journal-title":"Science"},{"key":"key20180108005637_b29-mmr-16-06-8200","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.bone.2006.09.023","article-title":"The molecular understanding of osteoclast differentiation","volume":"40","author":"Asagiri","year":"2007","journal-title":"Bone"},{"key":"key20180108005637_b30-mmr-16-06-8200","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1111\/j.1749-6632.2003.tb03214.x","article-title":"How proteases regulate bone morphogenesis","volume":"995","author":"Ortega","year":"2003","journal-title":"Ann N Y Acad Sci"},{"key":"key20180108005637_b31-mmr-16-06-8200","doi-asserted-by":"crossref","first-page":"3295","DOI":"10.1007\/s00421-011-2306-4","article-title":"Treadmill training regulates \u03b2-catenin signaling through phosphorylation of GSK-3\u03b2 in lumbar vertebrae of ovariectomized rats","volume":"112","author":"Bu","year":"2012","journal-title":"Eur J Appl Physiol"},{"key":"key20180108005637_b32-mmr-16-06-8200","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1097\/GME.0000000000000201","article-title":"Icariin prevents ovariectomy-induced bone loss and lowers marrow adipogenesis","volume":"21","author":"Li","year":"2014","journal-title":"Menopause"},{"key":"key20180108005637_b33-mmr-16-06-8200","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/s00223-004-0224-8","article-title":"Enhanced marrow adipogenesis and bone resorption in estrogen-deprived rats treated with the PPARgamma agonist BRL49653 (rosiglitazone)","volume":"75","author":"Sottile","year":"2004","journal-title":"Calcif Tissue Int"},{"key":"key20180108005637_b34-mmr-16-06-8200","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.intimp.2016.03.038","article-title":"Iguratimod (T-614) suppresses RANKL-induced osteoclast differentiation and migration in RAW264.7 cells via NF-\u03baB and MAPK pathways","volume":"35","author":"Gan","year":"2016","journal-title":"Int Immunopharmacol"},{"key":"key20180108005637_b35-mmr-16-06-8200","doi-asserted-by":"crossref","first-page":"44","DOI":"10.14715\/cmb\/2016.62.13.8","article-title":"Effect of iguratimod and methotrexate on RANKL and OPG expression in serum and IL-1\u03b2-induced fibroblast-like synoviocytes from patients with rheumatoid arthritis","volume":"62","author":"Wang","year":"2016","journal-title":"Cell Mol Biol (Noisy-le-grand)"},{"key":"key20180108005637_b36-mmr-16-06-8200","doi-asserted-by":"crossref","first-page":"534","DOI":"10.3109\/14397595.2014.998361","article-title":"Efficacy at 52 weeks of daily clinical use of iguratimod in patients with rheumatoid arthritis","volume":"25","author":"Okamura","year":"2015","journal-title":"Mod Rheumatol"}],"container-title":["Molecular Medicine Reports"],"original-title":[],"language":"en","deposited":{"date-parts":[[2018,1,8]],"date-time":"2018-01-08T01:55:25Z","timestamp":1515376525000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/mmr.2017.7648"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9,28]]},"references-count":36,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2017,9,28]]},"published-print":{"date-parts":[[2017,12]]}},"alternative-id":["10.3892\/mmr.2017.7648"],"URL":"https:\/\/doi.org\/10.3892\/mmr.2017.7648","relation":{},"ISSN":["1791-2997","1791-3004"],"issn-type":[{"value":"1791-2997","type":"print"},{"value":"1791-3004","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,9,28]]}}}